Our previous study demonstrated a significant elevation of IL-6, TNF-α, IL-1β, IL-17, IFN-γ and MCP-1 in colitis and showed that activation of the CB2 receptor by HU308 significantly reduces these cytokine levels [23]. This evidence concerns the gene CCL2 and colitis.